SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-038447
Filing Date
2017-06-07
Accepted
2017-06-07 20:58:37
Documents
2
Period of Report
2017-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1537
2 POA DOCUMENT poa.txt EX-24.3_729822 3273
  Complete submission text file 0001209191-17-038447.txt   6179
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752
Business Address
Freeman Jonathan E (Reporting) CIK: 0001708133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36304 | Film No.: 17898479